Report

Global Prostate Cancer Therapeutics Market Size study, By Therapy (Hormone Therapy, Targeted Therapy, Chemotherapy, and Biologic Therapy) and By Distribution Channel (Hospital Pharmacies, Online Sales, Retail Pharmacies, and Others), and Regional Forecasts 2020-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Prostate Cancer Therapeutics Market, by Region, 2018-2027 (USD Billion)
1.2.2. Prostate Cancer Therapeutics Market, by Therapy, 2018-2027 (USD Billion)
1.2.3. Prostate Cancer Therapeutics Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Prostate Cancer Therapeutics Market Definition & Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Prostate Cancer Therapeutics Market Dynamics
3.1. Prostate Cancer Therapeutics Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Prostate Cancer Therapeutics Market: Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Prostate Cancer Therapeutics Market, by Therapy
5.1. Market Snapshot
5.2. Global Prostate Cancer Therapeutics Market by Therapy, Performance - Potential Analysis
5.3. Global Prostate Cancer Therapeutics Market Estimates & Forecasts by Therapy, 2017-2027 (USD Billion)
5.4. Prostate Cancer Therapeutics Market, Sub Segment Analysis
5.4.1. Hormone Therapy
5.4.2. Targeted Therapy
5.4.3. Chemotherapy
5.4.4. Biologic Therapy
Chapter 6. Global Prostate Cancer Therapeutics Market, by Distribution Channel
6.1. Market Snapshot
6.2. Global Prostate Cancer Therapeutics Market by Distribution Channel, Performance - Potential Analysis
6.3. Global Prostate Cancer Therapeutics Market Estimates & Forecasts by Distribution Channel, 2017-2027 (USD Billion)
6.4. Prostate Cancer Therapeutics Market, Sub Segment Analysis
6.4.1. Hospital Pharmacies
6.4.2. Online Sales
6.4.3. Retail Pharmacies
6.4.4. Others
Chapter 7. Global Prostate Cancer Therapeutics Market, Regional Analysis
7.1. Prostate Cancer Therapeutics Market, Regional Market Snapshot
7.2. North America Prostate Cancer Therapeutics Market
7.2.1. U.S. Prostate Cancer Therapeutics Market
7.2.1.1. Therapy breakdown estimates & forecasts, 2017-2027
7.2.1.2. Distribution Channel breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Prostate Cancer Therapeutics Market
7.3. Europe Prostate Cancer Therapeutics Market Snapshot
7.3.1. U.K. Prostate Cancer Therapeutics Market
7.3.2. Germany Prostate Cancer Therapeutics Market
7.3.3. France Prostate Cancer Therapeutics Market
7.3.4. Spain Prostate Cancer Therapeutics Market
7.3.5. Italy Prostate Cancer Therapeutics Market
7.3.6. Rest of Europe Prostate Cancer Therapeutics Market
7.4. Asia-Pacific Prostate Cancer Therapeutics Market Snapshot
7.4.1. China Prostate Cancer Therapeutics Market
7.4.2. India Prostate Cancer Therapeutics Market
7.4.3. Japan Prostate Cancer Therapeutics Market
7.4.4. Australia Prostate Cancer Therapeutics Market
7.4.5. South Korea Prostate Cancer Therapeutics Market
7.4.6. Rest of Asia Pacific Prostate Cancer Therapeutics Market
7.5. Latin America Prostate Cancer Therapeutics Market Snapshot
7.5.1. Brazil Prostate Cancer Therapeutics Market
7.5.2. Mexico Prostate Cancer Therapeutics Market
7.6. Rest of The World Prostate Cancer Therapeutics Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Bayer AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Industry Summary
8.2.1.5. Recent Developments
8.2.2. Johnson & Johnson
8.2.3. Ipsen Group
8.2.4. Amgen, Inc.
8.2.5. Endo Pharmaceuticals, Inc.
8.2.6. AbbVie, Inc.
8.2.7. Pfizer, Inc.
8.2.8. AstraZeneca
8.2.9. Sanofi
8.2.10. Sanpower Group
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption